The study about Transfusing FFP during pediatric CPB with MUF increases blood clot strength

JRCT ID: jRCT1012230054

Registered date:15/12/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Congenital heart disease
• Date of first enrollment: 15/12/2023
• Target sample size: 40
• Study type: Interventional
• Intervention(s): Transfusing fresh frozen plasma during Modified Ultrafiltration.

Outcome(s)

• Primary Outcome: CFF of CPB
• Secondary Outcome: Bleeding volume, Operating time, ActF, CRT

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: <= 10age old
• Gender: Both
• Include criteria: children less than 10 years old, who require CPB
• Exclude criteria: crinical confounder including emergency case or massive bleeding etc

Related Information

• Primary Sponsor: Ogasawara Yuki